SCHEMBL29617744

SCHEMBL29617744

c1ccc(-c2n[nH]c3ncncc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 6/20 0.51
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 3/20 0.47
GAA P10253 2/20 0.47
HPGD P15428 2/20 0.47
MAPK10 P53779 2/20 0.47
ALPL P05186 1/20 0.47
IDO1 P14902 1/20 0.47
TTK P33981 1/20 0.47
JAK2 O60674 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
ATM Q13315 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PIM3 Q86V86 1/20 0.44
PIM2 Q9P1W9 1/20 0.44
YTHDC1 Q96MU7 1/20 0.42
YTHDF2 Q9Y5A9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1271230 1.00 PIM1 (0.51) PIM1ALDH1A1KDM4EGAAHPGD
SCHEMBL19352727 0.86 NUDT14 (0.44) PIM1NPC1RAB9A
SCHEMBL6055040 0.83 MKNK1 (0.41) PIM1KDM4EMAPK10ALPLMKNK1
SCHEMBL8742187 0.79 KMT2A (0.48) ALDH1A1KDM4EGAAMAPTCDK2
SCHEMBL1592857 0.76 ALDH1A1 (0.46) PIM1ALDH1A1KDM4EGAAHPGD
SCHEMBL14633242 0.76 NPSR1 (0.63) PIM1ALDH1A1KDM4EGAANPC1
SCHEMBL29930893 0.75 GSK3B (0.58) PIM1ALDH1A1KDM4EGAAHPGD
SCHEMBL8723687 0.75 MAPK1 (0.60) PIM1ALDH1A1HSD17B10PIM3PIM2
SCHEMBL30931548 0.74 ALDH1A1 (0.55) PIM1ALDH1A1KDM4EGAAHPGD
SCHEMBL1513056 0.74 ALDH1A1 (0.55) PIM1ALDH1A1KDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114685516-A Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-07-01 CN disclosed
CN-108431007-B Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-06-07 CN disclosed